Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Marx

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Marine Environmental Research|April 10, 2008
Effects of nanoparticles in Mytilus edulis gills and hepatopancreas - a new threat to marine life?Angela Koehler, Ute Marx, Katja Broeg, et al.
Environmental Science & Technology|November 4, 2021
Solid-Phase Extraction of Aquatic Organic Matter: Loading-Dependent Chemical Fractionation and Self-AssemblyXianyu Kong, Thomas Jendrossek, Kai-Uwe Ludwichowski, et al.
The Lancet. Neurology|April 26, 2020
Refining endpoints for stroke recovery trialsDirk M Hermann, Claudio L Bassetti, Ute Marx, et al.
European Child & Adolescent Psychiatry|October 10, 2024
Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension studyCelso Arango, Joerg M Fegert, Françoise Picarel-Blanchot, et al.
Biotechnology Journal|July 4, 2025
Co-Cultivation With New Glucose-Sparing Chlorella Algae Boosts Tissue Culture Efficiency by Reducing Cell WasteMelanie Oey, Ute Marx, Horst Joachim Schirra, et al.
The Lancet. Psychiatry|December 17, 2021
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countriesCelso Arango, Jan K Buitelaar, Jörg M Fegert, et al.
The Lancet. Neurology|February 23, 2020
Safety and efficacy of GABA<sub>A</sub> α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trialHugues Chabriat, Claudio L Bassetti, Ute Marx, et al.
Trials|February 5, 2020
Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II studyHugues Chabriat, Claudio L Bassetti, Ute Marx, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Marine Environmental Research|April 10, 2008
Effects of nanoparticles in Mytilus edulis gills and hepatopancreas - a new threat to marine life?Angela Koehler, Ute Marx, Katja Broeg, et al.
Environmental Science & Technology|November 4, 2021
Solid-Phase Extraction of Aquatic Organic Matter: Loading-Dependent Chemical Fractionation and Self-AssemblyXianyu Kong, Thomas Jendrossek, Kai-Uwe Ludwichowski, et al.
The Lancet. Neurology|April 26, 2020
Refining endpoints for stroke recovery trialsDirk M Hermann, Claudio L Bassetti, Ute Marx, et al.
European Child & Adolescent Psychiatry|October 10, 2024
Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension studyCelso Arango, Joerg M Fegert, Françoise Picarel-Blanchot, et al.
Biotechnology Journal|July 4, 2025
Co-Cultivation With New Glucose-Sparing Chlorella Algae Boosts Tissue Culture Efficiency by Reducing Cell WasteMelanie Oey, Ute Marx, Horst Joachim Schirra, et al.
The Lancet. Psychiatry|December 17, 2021
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countriesCelso Arango, Jan K Buitelaar, Jörg M Fegert, et al.
The Lancet. Neurology|February 23, 2020
Safety and efficacy of GABA<sub>A</sub> α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trialHugues Chabriat, Claudio L Bassetti, Ute Marx, et al.
Trials|February 5, 2020
Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II studyHugues Chabriat, Claudio L Bassetti, Ute Marx, et al.
Pageof 1